Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.167x

Based on the latest financial reports, Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) has a cash flow conversion efficiency ratio of -0.167x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-35.65 Million ≈ $-385.57K USD) by net assets (Rs213.04 Million ≈ $2.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biofil Chemicals & Pharmaceuticals Limit balance sheet quality to measure how much of total assets are equity-financed.

Biofil Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Biofil Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check BIOFILCHEM cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Biofil Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biofil Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pentanet Ltd AU:5GG	0.068x
Pila Pharma AB ST:PILA	-0.129x
Warehouse REIT plc LSE:WHR	0.027x
Gratifii Ltd AU:GTI	0.129x
Errawarra Resources Ltd AU:ERW	-0.002x
Openlearning Ltd AU:OLL	0.356x
Forza Land Indonesia Tbk PT JK:FORZ	-0.016x
Stonehorse Energy Ltd AU:SHE	-0.042x

Annual Cash Flow Conversion Efficiency for Biofil Chemicals & Pharmaceuticals Limited (2008–2025)

The table below shows the annual cash flow conversion efficiency of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Biofil Chemicals & Pharmaceuticals Limit.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs187.82 Million ≈ $2.03 Million	Rs-19.24 Million ≈ $-208.03K	-0.102x	-177.88%
2024-03-31	Rs182.03 Million ≈ $1.97 Million	Rs23.94 Million ≈ $258.87K	0.132x	+2135.04%
2023-03-31	Rs173.01 Million ≈ $1.87 Million	Rs-1.12 Million ≈ $-12.09K	-0.006x	+50.52%
2022-03-31	Rs168.38 Million ≈ $1.82 Million	Rs-2.20 Million ≈ $-23.78K	-0.013x	-118.96%
2021-03-31	Rs161.29 Million ≈ $1.74 Million	Rs11.11 Million ≈ $120.14K	0.069x	+14.64%
2020-03-31	Rs148.83 Million ≈ $1.61 Million	Rs8.94 Million ≈ $96.70K	0.060x	-34.69%
2019-03-31	Rs136.50 Million ≈ $1.48 Million	Rs12.56 Million ≈ $135.80K	0.092x	+161.29%
2018-03-31	Rs131.67 Million ≈ $1.42 Million	Rs4.64 Million ≈ $50.14K	0.035x	-37.16%
2017-03-31	Rs126.96 Million ≈ $1.37 Million	Rs7.11 Million ≈ $76.94K	0.056x	+347.18%
2016-03-31	Rs109.07 Million ≈ $1.18 Million	Rs1.37 Million ≈ $14.78K	0.013x	+1051.90%
2015-03-31	Rs84.15 Million ≈ $910.03K	Rs91.53K ≈ $989.89	0.001x	-95.95%
2014-03-31	Rs78.63 Million ≈ $850.35K	Rs2.11 Million ≈ $22.84K	0.027x	+253.87%
2013-03-31	Rs73.62 Million ≈ $796.22K	Rs-1.29 Million ≈ $-13.90K	-0.017x	+37.76%
2012-03-31	Rs68.36 Million ≈ $739.31K	Rs-1.92 Million ≈ $-20.73K	-0.028x	+84.95%
2011-03-31	Rs67.02 Million ≈ $724.79K	Rs-12.49 Million ≈ $-135.03K	-0.186x	-111.61%
2010-03-31	Rs17.27 Million ≈ $186.81K	Rs27.73 Million ≈ $299.89K	1.605x	+993.82%
2009-03-31	Rs11.99 Million ≈ $129.64K	Rs-2.15 Million ≈ $-23.28K	-0.180x	-173.13%
2008-03-31	Rs14.78 Million ≈ $159.86K	Rs3.63 Million ≈ $39.26K	0.246x	--

About Biofil Chemicals & Pharmaceuticals Limited

NSE:BIOFILCHEM India Drug Manufacturers - Specialty & Generic

Market Cap

$5.82 Million

Rs538.17 Million INR

Market Cap Rank

#28264 Global

#1574 in India

Share Price

Rs33.07

Change (1 day)

+3.54%

52-Week Range

Rs25.79 - Rs46.34

All Time High

Rs339.15